Thrive Capital’s 2022 early-stage VC fund grew from a $516M vehicle to more than $3.7B in value as of the end of June, buoyed by early investments in OpenAI, SpaceX, and Anduril. The scale of the mark-to-market gain is strongly positive for the manager’s performance profile, though the news is unlikely to move public markets meaningfully.
Thrive Capital’s 2022 early-stage VC fund grew from a $516M vehicle to more than $3.7B in value as of the end of June, buoyed by early investments in OpenAI, SpaceX, and Anduril. The scale of the mark-to-market gain is strongly positive for the manager’s performance profile, though the news is unlikely to move public markets meaningfully.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
